INNOVATE Corp. — Major Shareholding Notification 2021

Jul 7, 2021

SC 13D/A 1 tm2121622d1_sc13da.htm SCHEDULE 13D/A

Field: Rule-Page

Field: /Rule-Page

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

SCHEDULE 13D

(Rule 13d-101)

Information to be Included in Statements Filed Pursuant to § 240.13d-1(a) and

Amendments Thereto Filed Pursuant to § 240.13d-2(a)

Under the Securities Exchange Act of 1934

(Amendment No. 9)*

HC2 Holdings, Inc.

(Name of Issuer)

Common Stock, par value $0.001 per share

(Title of Class of Securities)

404139107

(CUSIP Number)

Avram Glazer

Lancer Capital LLC

777 South Flagler Drive

Suite 800, West Tower

West Palm Beach, Florida 33401

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

July 6, 2021

(Date of Event which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. ¨

Note : Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See § 240.13d-7 for other parties to whom copies are to be sent.

Field: Rule-Page

Field: /Rule-Page

• The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes ).

Field: Rule-Page

Field: /Rule-Page

Field: Page; Sequence: 1

Field: /Page

CUSIP No. 404139107 13D Page 2 of 8 Pages

1	NAMES OF REPORTING PERSONS Lancer Capital LLC
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP	(a) ¨ (b) ¨
3	SEC USE ONLY
4	SOURCE OF FUNDS PF
5	Check
if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e) ¨
6	CITIZENSHIP OR PLACE OF ORGANIZATION Delaware

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH	SOLE VOTING POWER 19,452,548 (1)
8	SHARED VOTING POWER 0
9	SOLE DISPOSITIVE POWER 19,452,548 (1)
10	SHARED DISPOSITIVE POWER 0

11	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 19,452,548 (1)
12	CHECK
IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES	¨
13	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 24.9% (1)(2)
14	TYPE OF REPORTING PERSON OO

(1) Includes 468,594 shares of Common Stock of HC2 Holdings, Inc. (the “Issuer”) issuable upon conversion of $2,000,000 principal amount of the Issuer’s 7.5% Convertible Senior Notes due 2026.

(2) Based on 77,612,041 shares of Common Stock of the Issuer outstanding as of April 30, 2021, as reported in the Issuer’s Form 10Q filed with the Securities and Exchange Commission on May 7, 2021.

Field: Page; Sequence: 2

Field: /Page

CUSIP No. 404139107 13D Page 3 of 8 Pages

1	NAMES OF REPORTING PERSONS Avram Glazer
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP	(a) ¨ (b) ¨
3	SEC USE ONLY
4	SOURCE OF FUNDS PF
5	Check if
disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e) ¨
6	CITIZENSHIP OR PLACE OF ORGANIZATION United States of America

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH	SOLE VOTING POWER 22,625,700 (1)
8	SHARED VOTING POWER 0
9	SOLE DISPOSITIVE POWER 22,625,700 (1)
10	SHARED DISPOSITIVE POWER 0

11	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 22,625,700 (1)
12	CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES	¨
13	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 29.0% (1)(2)
14	TYPE OF REPORTING PERSON IN

(1) Includes 468,594 shares of Common Stock of HC2 Holdings, Inc. (the “Issuer”) issuable upon conversion of $2,000,000 principal amount of the Issuer’s 7.5% Convertible Senior Notes due 2026.

(2) Based on 77,612,041 shares of Common Stock of the Issuer outstanding as of April 30, 2021, as reported in the Issuer’s Form 10Q filed with the Securities and Exchange Commission on May 7, 2021.

Field: Page; Sequence: 3

Field: /Page

CUSIP No. 404139107 13D Page 4 of 8 Pages

1	NAMES OF REPORTING PERSONS Avram Glazer Irrevocable Exempt Trust
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP	(a) ¨ (b) ¨
3	SEC USE ONLY
4	SOURCE OF FUNDS OO
5	Check
if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e) ¨
6	CITIZENSHIP OR PLACE OF ORGANIZATION United States of America

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH	SOLE VOTING POWER 22,591,953 (1)
8	SHARED VOTING POWER 0
9	SOLE DISPOSITIVE POWER 22,591,953 (1)
10	SHARED DISPOSITIVE POWER 0

11	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 22,591,953 (1)
12	CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES	¨
13	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 28.9% (1)(2)
14	TYPE OF REPORTING PERSON OO

(1) Includes 468,594 shares of Common Stock of HC2 Holdings, Inc. (the “Issuer”) issuable upon conversion of $2,000,000 principal amount of the Issuer’s 7.5% Convertible Senior Notes due 2026.

(2) Based on 77,612,041 shares of Common Stock of the Issuer outstanding as of April 30, 2021, as reported in the Issuer’s Form 10Q filed with the Securities and Exchange Commission on May 7, 2021.

Field: Page; Sequence: 4

Field: /Page

CUSIP No. 404139107 13D Page 5 of 8 Pages

Explanatory Note

This Amendment No. 7 to Schedule 13D (“Amendment No. 7”) amends and supplements the Schedule 13D filed with the United States Securities and Exchange Commission on April 23, 2020 (the “Schedule 13D”), relating to the common stock, $0.001 par value per share (the “Common Stock”), of HC2 Holdings, Inc., a Delaware corporation (the “Issuer”). Capitalized terms used herein without definition shall have the meaning set forth in the Schedule 13D.

ITEM 4. Purpose of the Transaction.

Item 4 of the Schedule 13D is hereby amended to include the following:

The previously disclosed 10b5-1 Purchase Plan was terminated as of July 6, 2021.

ITEM 5. Interest in Securities of the Issuer.

Item 5 of the Schedule 13D is hereby amended and restated in its entirety as follows:

(a) As of the date hereof, Lancer beneficially owns directly 19,452,548 shares of Common Stock representing 24.9% of the Issuer’s Common Stock, the Trust beneficially owns 22,591,953 shares of Common Stock representing 28.9% of the Issuer's Common Stock, and Mr. Glazer beneficially owns 22,625,700 shares of Common Stock representing 29.0% of the Issuer's Common Stock, based on 77,612,041 shares of Common Stock of the Issuer outstanding as of April 30, 2021, as reported in the Issuer’s Form 10Q filed with the Securities and Exchange Commission on May 7, 2021.

(b) The following sets forth, as of the date of this Statement, the aggregate number and percentage of Common Stock beneficially owned by each of the Reporting Persons, as well as the number of Common Stock as to which each Reporting Person has the sole power to vote or to direct the vote, sole power to dispose or to direct the disposition, or shared power to dispose or to direct the disposition of.

Reporting Person — Avram Glazer	22,625,700	29.0 %	22,625,700	0	22,625,700	0
Lancer Capital LLC	19,452,548	24.9 %	19,452,548	0	19,452,548	0
Avram Glazer Irrevocable Exempt Trust	22,591,953	28.9 %	22,591,953	0	22,591,953	0

Lancer is the record holder of 19,452,548 shares of Common Stock, the Trust is the record holder of 3,139,405 shares of Common Stock, and Mr. Glazer is the record holder of 33,747 shares of Common Stock. Mr. Glazer is the sole owner of Lancer and the Trustee of the Trust, and in such capacities may be deemed to beneficially own the shares held of record by Lancer and the Trust. The Trust is the sole owner of Lancer, and in such capacity may be deemed to beneficially own the shares held of record by Lancer and the Trust

Field: Page; Sequence: 5

Field: /Page

CUSIP No. 404139107 13D Page 6 of 8 Pages

(c) The transactions in the Common Stock by the Reporting Persons during the past sixty days are set forth in Schedule A and are incorporated herein by reference.

(d) None.

(e) Not applicable.

Item 7. Materials to be Filed as Exhibits.

Exhibit Number	Description
1	Joint Filing Agreement by and between Lancer Capital LLC and Avram Glazer, dated July 7, 2021.

Field: Page; Sequence: 6

Field: /Page

CUSIP No. 404139107 13D Page 7 of 8 Pages

SIGNATURES

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Date : July 7, 2021

Avram Glazer
By:	/s/ Avram Glazer
Name:	Avram Glazer
Lancer Capital LLC
By:	Avram Glazer
By:	/s/ Avram Glazer
Name:	Avram Glazer
Title:	Sole Member
Avram Glazer Irrevocable Exempt Trust
By:	Avram Glazer
By:	/s/ Avram Glazer
Name:	Avram Glazer
Title:	Trustee

Field: Page; Sequence: 7

Field: /Page

CUSIP No. 404139107 13D Page 8 of 8 Pages

Schedule A

Transactions in the Common Stock of the Issuer by Reporting Persons During the Past 60 Days

Reporting Person	Date of Transaction	Buy/Sell	Number of Shares Purchased/(Sold)	Price Per Share 1
Avram Glazer Irrevocable Exempt Trust	5/20/2021	Buy	22,394	$3.94
Avram Glazer Irrevocable Exempt Trust	5/21/2021	Buy	16,191	$3.96
Avram Glazer Irrevocable Exempt Trust	5/26/2021	Buy	23,128	$4.00
Avram Glazer Irrevocable Exempt Trust	5/28/2021	Buy	3,327	$3.99
Avram Glazer Irrevocable Exempt Trust	6/1/2021	Buy	971	$4.00
Avram Glazer Irrevocable Exempt Trust	6/18/2021	Buy	71,000	$3.98
Avram Glazer Irrevocable Exempt Trust	6/21/2021	Buy	11,588	$3.93
Avram Glazer Irrevocable Exempt Trust	6/22/2021	Buy	15,492	$4.00
Avram Glazer Irrevocable Exempt Trust	6/23/2021	Buy	27,725	$3.99
Avram Glazer Irrevocable Exempt Trust	6/29/2021	Buy	33,829	$4.00
Avram Glazer Irrevocable Exempt Trust	7/1/2021	Buy	29,322	$3.97
Avram Glazer Irrevocable Exempt Trust	7/2/2021	Buy	26,223	$4.97
Avram Glazer Irrevocable Exempt Trust	7/6/2021	Buy	116,565	$3.93

Field: Rule-Page

Field: /Rule-Page

1 Excluding any brokerage commissions.

Field: Page; Sequence: 8; Options: Last

Field: /Page